ArticleFrontiers in pharmacology2023

Methylsulfonylmethane ameliorates metabolic-associated fatty liver disease by restoring autophagy flux via AMPK/mTOR/ULK1 signaling pathway.

Daewon Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.